House bill proposes reauthorization of the Breast Cancer Research Stamp
April 16, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently in_committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
The bill maintains a dedicated funding stream for breast cancer research by allowing the public to continue purchasing stamps at a premium price, with the extra funds directed to federal research programs.
Potentially affected actors named in the source documents. Mention is not a position.
U.S. Postal Service
The agency is responsible for the issuance and sale of the stamp.
Breast cancer research programs
These programs receive funding generated by the surcharge on the stamps.
Current stage: in_committee.
Floor Vote.
Summary
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What does this bill do?
Is this bill currently law?
Why It Matters
The bill maintains a dedicated funding stream for breast cancer research by allowing the public to continue purchasing stamps at a premium price, with the extra funds directed to federal research programs.
News Coverage
Connected Entities
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy5Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools